Cargando…
COVID-19 and inflammatory bowel disease: A pathophysiological assessment
Coronavirus disease-2019 (COVID-19), caused by SARS-CoV-2, has led to the ongoing global pandemic. Although most patients experience no or only mild symptoms, some patients can develop severe illness, such as progressive pneumonia, acute respiratory distress syndrome, secondary hemophagocytic lympho...
Autores principales: | Yang, Chunxiu, Xiao, Shu-Yuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834878/ https://www.ncbi.nlm.nih.gov/pubmed/33433350 http://dx.doi.org/10.1016/j.biopha.2021.111233 |
Ejemplares similares
-
Inflammatory bowel disease in Korea: epidemiology and pathophysiology
por: Lee, Jung Won, et al.
Publicado: (2022) -
Pathophysiology of Inflammatory Bowel Disease: Innate Immune System
por: Saez, Angela, et al.
Publicado: (2023) -
Adipokine-Modulated Immunological Homeostasis Shapes the Pathophysiology of Inflammatory Bowel Disease
por: Tsai, Yi-Wen, et al.
Publicado: (2020) -
Molecular Pathophysiology of Epithelial Barrier Dysfunction in Inflammatory Bowel Diseases
por: Lee, Jessica Y., et al.
Publicado: (2018) -
CD4 T-Cell Subsets and the Pathophysiology of Inflammatory Bowel Disease
por: Gomez-Bris, Raquel, et al.
Publicado: (2023)